4884 Share Price Performance
JP¥415.00
-362.00 (-46.59%)
Price JP¥415.00
Share Pricen/a
Kringle Pharma, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
4884 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Kringle Pharma, Inc. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 11, 2026
- -123.20
- 100.00%
- -1,246.73%
- 0%
About 4884
- Founded
- 2001
- Employees
- 17
- CEO
- WebsiteView website
Kringle Pharma, Inc. engages in research and develops therapeutic agents for the treatment of intractable diseases in Japan. The company develops HGF products for the treatment of acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scar, and acute kidney injury. Kringle Pharma, Inc. was incorporated in 2001 and is based in Kita, Japan.
